Corrigendum: Vaccine safety surveillance using routinely collected healthcare data-An empirical evaluation of epidemiological designs

Front Pharmacol. 2022 Nov 24:13:1088973. doi: 10.3389/fphar.2022.1088973. eCollection 2022.

Martijn J Schuemie^{1

2

3}, Faaizah Arshad^{1

3}, Nicole Pratt⁴, Fredrik Nyberg⁵, Thamir M Alshammari⁶, George Hripcsak^{1

7}, Patrick Ryan^{1

2

7}, Daniel Prieto-Alhambra^{8

9}, Lana Y H Lai¹⁰, Xintong Li¹¹, Stephen Fortin², Evan Minty¹⁰, Marc A Suchard^{1

3

12}

¹ Observational Health Data Sciences and Informatics, New York, NY, United States.
² Observational Health Data Analytics, Janssen R&D, Titusville, NJ, United States.
³ Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, United States.
⁴ Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
⁵ School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
⁶ College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.
⁷ Department of Biomedical Informatics, Columbia University, New York, NY, United States.
⁸ Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, United Kingdom.
⁹ Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.
¹⁰ O'Brien Institute for Public Health, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.
¹¹ Division of Medical Sciences, University of Manchester, Manchester, United Kingdom.
¹² Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, United States.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.893484.].

Keywords: adverse event; methods; routinely collected data; surveillance; vaccine safely.